News
Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
JNJ eyes $50B in oncology sales by 2030, driven by drugs like Darzalex, Erleada, new launches including Carvykti and Tecvayli, and its cancer pipeline.
9h
GlobalData on MSNCan rare disease research in the US thrive under the new administration?As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.
Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...
GE Aerospace raised its full-year earnings outlook and beat expectations on its top and bottom lines in the second quarter. PepsiCo said its business remained resilient during the second quarter, ...
18h
BabyCenter on MSNIs it safe to get vaccinated during pregnancy?Find out which vaccines are recommended while you're pregnant to protect you and your baby, and which you'll need to wait on.
The agreement, signed Monday between CMS and DHS, has not been announced publicly, AP reports. Other Trump administration ...
Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy appeared at risk.
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results